ARTICLE | Management Tracks
Ardelyx names J&J alum Hohenleitner CFO
Plus: Yifang Wu succeeds Wei Fu as chair of Everest and updates from Zura and ImageneBio
October 14, 2025 1:09 AM UTC
Ardelyx Inc. (NASDAQ:ARDX) named Sue Hohenleitner CFO. She was most recently VP and CFO of the Innovative Medicine North America division of Johnson & Johnson (NASDAQ:JNJ). Ardelyx markets SLC9A3 inhibitor tenapanor as Ibsrela to treat irritable bowel syndrome with constipation, and as Xphozah to treat hyperphosphatemia.
Everest Medicines Ltd. (HKEX:1952) named Wei Fu honorary chairman and a director as he steps down from the chairman role. The company named Yifang Wu chairman and executive director. Wu is an executive operating partner of CBC Group, an Everest shareholder, and the former chairman and CEO of Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKEX:2196)...